Your browser doesn't support javascript.
loading
The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial.
Ma, Qi; Hei, Xiaoyan; Zhu, Shiqiang; Tian, Xinbao; Chen, Yundong; Zhu, Ning; Zhang, Jinchen; Feng, Ping; Liu, Yujuan; Xing, Lijuan; Li, Xiaojun; Liu, Qiang; Li, Fengqiao; Li, Xiaolong; Lai, Zheying; Lin, Ruizhu; Xu, Jianfeng.
Afiliação
  • Ma Q; General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Hei X; Clinical College of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Zhu S; People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China.
  • Tian X; Clinical College of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Chen Y; People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China.
  • Zhu N; Clinical College of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Zhang J; Clinical College of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Feng P; General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Liu Y; General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Xing L; General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Li X; General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Liu Q; General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Li F; General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Li X; General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Lai Z; General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Lin R; Clinical College of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Xu J; Clinical College of Ningxia Medical University, Yinchuan, Ningxia, China.
Article em En | MEDLINE | ID: mdl-35656456
Knee osteoarthritis is a common chronic degenerative joint disease in middle-aged and elderly people. Intra-articular injection for the treatment of knee osteoarthritis is a regularly utilized nonsurgical treatment in modern medicine. Hyaluronic acid (HA) and platelet-rich plasma (PRP) are two frequently employed intra-articular devices. Hyaluronic acid (HA) is an accepted nonsurgical treatment for symptomatic KOA, and platelet-rich plasma is a popular option in the treatment of KOA in recent years. The purpose of this research is to compare the efficacy and safety of intra-articular injection of platelet-rich plasma (PRP) versus hyaluronic acid (HA) on the pain score scale, knee function, and related inflammatory biomarkers in KOA patients using a clinical randomized controlled trial. Participants are being randomized into either the hyaluronic acid (HA) or into the platelet-rich plasma (PRP) group. All patients receive 4 weeks of treatment (once a week), and well-being support and quadriceps training (3 times a week). The primary outcomes are measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the visual analog scale (VAS). The secondary outcomes include the activities of daily living score, erythrocyte sedimentation rate, C-reactive protein testing, interleukin-6 levels, and X-ray examination. In order to monitor the occurrence of irregularities and abnormalities, patients are assessed at each visit, and restorative treatment is given if necessary. The results of this clinical trial will verify the efficacy of PRP and HA in the treatment of KOA and provide important evidence for the clinical treatment of KOA. The trial was enlisted at the Chinese Clinical Trial Registry on 26 September 2020 (ChiCTR2000038635).

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Evid Based Complement Alternat Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Evid Based Complement Alternat Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China